Saltar al contenido
Merck

Up-regulation of SUMO E3 ligases during lung schistosomula and adult worm stages.

Parasitology research (2014-05-08)
Roberta V Pereira, Matheus de S Gomes, Fernanda Janku Cabral, Liana K Jannotti-Passos, Vanderlei Rodrigues, William de Castro-Borges, Renata Guerra-Sá
RESUMEN

Small ubiquitin-like modifier (SUMO) conjugation of proteins occurs through a concert action of enzymes using a similar ubiquitination mechanism. After a C-terminal peptide is cleaved from the SUMO precursor by a protease to reveal a di-glycine motif, SUMO is activated by an E1 enzyme (Aos1/Uba2) and conjugated to target proteins by the sole E2 enzyme (Ubc9) guided to the appropriate substrates by the SUMO E3 ligase. Previous reports from our group showed that Schistosoma mansoni has two paralogs of SUMO: one E2 conjugation Ubc9 and two SUMO-specific proteases (SENPs). The differential gene expression profile observed for SUMO pathway genes throughout the S. mansoni life cycle attests for the distinct patterns of SUMO conjugates observed during parasite development particularly during the cercariae to schistosomula transition. To continue this investigation, we here analysed the repertoire of SUMO E3 ligases and their expression profiles during cercariae/schistosomula transition. In silico analysis through S. mansoni databases showed two conserved SUMO E3 ligases: protein inhibitor of activated STAT (PIAS) and Ran-binding protein 2 (RanBP2). Furthermore, expression levels of the SUMO E3 ligases were measured by qRT-PCR using total RNA from cercariae, adult worms and mechanically transformed schistosomula. Our data showed an up-regulation of expression in lung schistosomula and adult worm stages. In conclusion, the differential expression of SmPIAS and SmRanBP2 during schistosomula development was similar to the expression levels of all genes related to SUMO conjugation, thereby suggesting that the control of protein activity, localisation or stability during cercariae to schistosomula transition is SUMO-dependent.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Cloroformo, contains 100-200 ppm amylenes as stabilizer, ≥99.5%
Sigma-Aldrich
Cloroformo, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%, contains amylenes as stabilizer
Sigma-Aldrich
Cloroformo, contains ethanol as stabilizer, ACS reagent, ≥99.8%
Sigma-Aldrich
Cloroformo, suitable for HPLC, ≥99.8%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
Cloroformo, contains amylenes as stabilizer, ACS reagent, ≥99.8%
Sigma-Aldrich
Cloroformo, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
Cloroformo, ACS spectrophotometric grade, ≥99.8%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
Cloroformo, ReagentPlus®, ≥99.8%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
Cloroformo, anhydrous, contains amylenes as stabilizer, ≥99%
Sigma-Aldrich
Cloroformo, contains ethanol as stabilizer, meets analytical specification of BP, 99-99.4% (GC)
Sigma-Aldrich
Cloroformo, biotech. grade, ≥99.8%, contains 0.5-1.0% ethanol as stabilizer
Supelco
Cloroformo, analytical standard
Supelco
Cloroformo, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Cloroformo, ≥99%, PCR Reagent, contains amylenes as stabilizer
Supelco
Cloroformo, Pharmaceutical Secondary Standard; Certified Reference Material